{"id":"W2079916847","doi":"10.1055/s-2000-9941","title":"Antiviral Therapy for Patients with Chronic Hepatitis C","year":2000,"lang":"en","type":"review","venue":"Seminars in Liver Disease","topic":"Hepatitis C virus research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Ribavirin; Internal medicine; Alpha interferon; Hepatitis C; Interferon; Hepatitis; Interferon alfa; Combination therapy; Incidence (geometry); Randomized controlled trial; Chronic hepatitis; Clinical trial; Immunology; Gastroenterology; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000151461,0.000522317,0.001424331,0.0004316593,0.00007184486,0.00003596409,0.0002826141,0.000225905,0.000617462],"category_scores_gemma":[0.00009190421,0.0003922447,0.0004434641,0.0004734044,0.0001870546,0.000133532,0.00005514534,0.0004591782,0.000185159],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007532433,"about_ca_system_score_gemma":0.001868291,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000164007,"about_ca_topic_score_gemma":0.00008401242,"domain_scores_codex":[0.9973048,0.0001767567,0.000481512,0.0007199193,0.0006445292,0.0006725112],"domain_scores_gemma":[0.9984182,0.0002092896,0.000137607,0.000705261,0.0001143429,0.0004153294],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000528049,0.0006419815,0.04690099,0.01269845,0.0001344066,0.0003535633,0.0000281264,1.235903e-7,7.098814e-9,0.000005834124,0.002492126,0.9362164],"study_design_scores_gemma":[0.002370055,0.001273471,0.009837329,0.03656266,0.0004451217,0.00000165303,4.498511e-7,0.0000273364,1.607888e-7,0.000009442891,0.9490566,0.0004157529],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001699701,0.9901664,0.000003278293,0.00001465108,0.0000831686,0.005959292,0.001184873,0.0000467291,0.0008419547],"genre_scores_gemma":[0.0006901565,0.9939888,0.0001828135,0.00006605328,0.0002656671,0.001366421,0.001986149,0.0001652161,0.001288771],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9465644,"threshold_uncertainty_score":0.999853,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02848770718642561,"score_gpt":0.3405562661266179,"score_spread":0.3120685589401923,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}